Feb 1, 2025

Feb 1, 2025

Feb 1, 2025

A New Way to Produce Hyperketonemia: Use of Ketone Ester in a Case of Alzheimer’s Disease

A New Way to Produce Hyperketonemia: Use of Ketone Ester in a Case of Alzheimer’s Disease

A New Way to Produce Hyperketonemia: Use of Ketone Ester in a Case of Alzheimer’s Disease

This case study demonstrates the potential of ketone monoester (KME) supplementation to support cognitive function in advanced Alzheimer’s disease. A 63-year-old man with a long-standing diagnosis of AD showed marked improvements in mood, memory, daily function, and self-care when given oral KME over 20 months. Elevated plasma BHB levels (3–7 mM) closely tracked with behavioral and cognitive gains. Unlike ketogenic diets or MCTs, KME induced therapeutic hyperketonemia without dietary changes, offering a practical and potent approach to brain energy rescue in neurodegenerative conditions.

This case study demonstrates the potential of ketone monoester (KME) supplementation to support cognitive function in advanced Alzheimer’s disease. A 63-year-old man with a long-standing diagnosis of AD showed marked improvements in mood, memory, daily function, and self-care when given oral KME over 20 months. Elevated plasma BHB levels (3–7 mM) closely tracked with behavioral and cognitive gains. Unlike ketogenic diets or MCTs, KME induced therapeutic hyperketonemia without dietary changes, offering a practical and potent approach to brain energy rescue in neurodegenerative conditions.

Summary of

A New Way to Produce Hyperketonemia: Use of Ketone Ester in a Case of Alzheimer’s Disease

By

Mary T. Newport

Mary T. Newport

, et al.

, et al.

Purpose

To test whether prolonged use of a ketone monoester supplement could safely elevate plasma ketones and improve cognitive and daily function in a patient with Alzheimer’s disease.

Methods

A 63-year-old male with advanced Alzheimer’s was given oral ketone monoester (KME) over a 20-month period, while continuing his usual diet. Plasma BHB levels and cognitive/behavioral changes were monitored. Prior to KME, he had received medium-chain triglycerides (MCTs) with some improvement, but later regressed during a drug trial.

Results

KME induced plasma BHB levels of 3–7 mM, significantly higher than those achieved with MCTs. Noticeable improvements in self-care, mood, memory, and daily activities were reported within days of initiating KME and sustained throughout the treatment period. The patient regained independence in dressing, hygiene, and household tasks. Lipid markers also improved, with reductions in total and LDL cholesterol.

Conclusion

Ketone monoester safely induced robust hyperketonemia and was associated with significant functional and cognitive improvements in an Alzheimer’s patient. This suggests a promising, diet-independent strategy to overcome brain energy deficits characteristic of AD. Larger studies are needed to confirm these findings.

Backed by Science.
Built for Real Results.

Our patented ketone formula isn’t just clean—it’s clinically validated to fuel the brain, body, and metabolism across real-world scenarios.

Products to Meet You Where You Are on Your Wellness Journey. 

Products to Meet You Where You Are on Your Wellness Journey. 

Products to Meet You Where You Are on Your Wellness Journey. 

If you want to restore your metabolic health, defeat that midday slump or achieve your personal best, Tecton Ketones is launching a range of specifically formulated products to help reach your goals.

If you want to restore your metabolic health, defeat that midday slump or achieve your personal best, Tecton Ketones is launching a range of specifically formulated products to help reach your goals.

If you want to restore your metabolic health, defeat that midday slump or achieve your personal best, Tecton Ketones is launching a range of specifically formulated products to help reach your goals.